Clinical Trials Directory

Trials / Unknown

UnknownNCT01340495

Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy

Pilot Study of Proton Radiation Therapy for Invasive Breast Carcinoma Following Mastectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study we are looking at a type of radiation called proton radiation which is known to spare surrounding tissue and organs from radiation. The proton radiation will be delivered using 3D conformal proton radiation or scanned beam/IMPT (Intensity Modulated Proton Radiation Treatment). Proton radiation delivers no dose beyond the region requiring treatment. This may reduce side effects that patients would normally experience with conventional radiation therapy or other means of delivering proton radiation therapy. In this study we are evaluating the effectiveness of using proton radiation delivered to reduce side effects association with radiation treatment.

Detailed description

Proton radiation will be delivered daily for approximately 5 1/2 weeks. Patients will be assessed weekly for any side effects they may be experiencing. Patients will have follow-up visits 4 weeks after proton therapy ends, at 6 months, 12 months, and then every year for up to five years after treatment. Follow-up visits will include a physical examination, radiological imaging (if necessary), echocardiogram, and laboratory tests.

Conditions

Interventions

TypeNameDescription
RADIATIONProton Radiation45-50.4 Gy(RBE) to the chest wall and 45-50.5 Gy(RBE) once daily, 5 days per week, for approximately 5 1/2 weeks

Timeline

Start date
2011-06-01
Primary completion
2017-04-01
Completion
2022-01-01
First posted
2011-04-22
Last updated
2021-01-05
Results posted
2018-04-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01340495. Inclusion in this directory is not an endorsement.